What this is
- How it works
- How it works isn't classified yet
- Tested for
- Parenteral Nutrition
- Main trialPhase 3
- “A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 versus NTCB-C in patients who require parenteral nutrition”In the company’s words, NCT06625957 on ClinicalTrials.gov
Other drugs for Parenteral Nutrition
- Choline ChlorideProtara Therapeutics · Phase 2/3
- SetmelanotideRhythm · Phase 2
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 18 Jul 2025 | Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026